Figure 1 — Efficacy of first-line tyrosine kinase inhibitor between unresectable stage III and stage IV EGFR-mutated non-small cell lung cancer patients

Research Paper|Volume 15, Issue 11|pp. 5066–5074

Efficacy of first-line tyrosine kinase inhibitor between unresectable stage III and stage IV EGFR-mutated non-small cell lung cancer patients

Back to articleFigure 1(1 of 5)

100%

Figure 1.Frequency of initial treatment modalities for EGFR-mutated non-small cell lung cancer patients. (A) stage III. (B) stage IV. EGFR: Epidermal growth factor receptor. TKI: tyrosine kinase inhibitor.